Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.86M Buy
22,807
+12,681
+125% +$885K 0.04% 382
2026
Q1
$611K Buy
10,126
+51
+0.5% +$3.45K 0.02% 548
2025
Q4
$639K Sell
10,075
-10,315
-51% -$669K 0.02% 541
2025
Q3
$1.44M Sell
20,390
-6,966
-25% -$490K 0.04% 362
2025
Q2
$1.76M Sell
27,356
-3,558
-12% -$224K 0.05% 327
2025
Q1
$2.15M Sell
30,914
-4,192
-12% -$314K 0.07% 276
2024
Q4
$2.55M Buy
+35,106
New +$2.81M 0.08% 238

Other funds holding MAS

Cary Street Partners's MAS Position: Q2 2026 in Review

Cary Street Partners increased its Masco (MAS) stake by 125% in Q2 2026, buying an estimated $885K and bringing the position to 22,807 shares worth $1.86M. The position accounts for 0.04% of the portfolio, ranked #382.

Cary Street Partners first reported a position in MAS in Q4 2024 and has held it in 7 quarters since. The position peaked at $2.55M in Q4 2024. 915 funds tracked by Wall St. Rank hold MAS as of Q2 2026.

  • Cary Street Partners held 22,807 shares of Masco worth $1.86M as of Q2 2026.
  • Cary Street Partners bought 12,681 Masco shares in Q2 2026, an estimated $885K.
  • Masco made up 0.04% of Cary Street Partners's portfolio in Q2 2026, its #382 holding.
  • Cary Street Partners first reported a position in Masco in Q4 2024 and has held it in 7 quarters since.
  • Cary Street Partners's Masco position peaked at $2.55M in Q4 2024.
  • 915 funds tracked by Wall St. Rank held Masco as of Q2 2026.

Based on Cary Street Partners's 13F filing for Q2 2026, filed 17 Jul 2026.